Novo Nordisk $175m diabetes plant to create 450 jobs
Novo Nordisk is building a 2.1bn Danish kroner ($175m) insulin and obesity drug plant in Denmark set to employ 450 people.
Novo Nordisk is building a 2.1bn Danish kroner ($175m) insulin and obesity drug plant in Denmark set to employ 450 people.
Takeda has taken a stake in Belgian bioprocessing start-up Univercells as part of a programme aimed at supplying low-cost vaccines to lower-income countries.
While pharma is increasing use of automation and data integration tools in process development and manufacturing, it lags behind in electronic documentation of quality control, according to Lonza Biologics QC director Jessica Jean.